In 40 female patients with invasive breast carcinoma we analyzed IL-33, IL-33R and VEGF expression in tumor cells in order to investigate the relevance of experimental findings in mice for corresponding human pathology. The gene discussed is IL33; the disease is invasive breast carcinoma.